Back to mobile site

Marvell (MRVL) PT Lowered to $13 at BofA/Merrill Lynch on Weak Qtr

February 20, 2015 7:42 AM EST Send to a Friend
BofA/Merrill Lynch analyst Vivek Arya reiterated an Underperform rating and lowered its price target on Marvell (NASDAQ: MRVL) to $13.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login